Second-Opinion and Online Consultation Platforms: What Doctors Should Check Before Signing Up

Second-Opinion and Online Consultation Platforms: What Doctors Should Check Before Signing Up

Second-Opinion and Online Consultation Platforms: What Doctors Should Know Before Signing Up

Second-opinion and online consultation platforms have become a routine part of how Indian doctors, particularly specialists, extend their practice beyond their physical clinic. What is less routine is doctors reading the platform agreement closely enough to understand exactly where regulatory responsibility sits once they click accept, since the legal obligations of telemedicine practice do not shift to the platform simply because the platform built the interface.

The Regulatory Floor Every Platform Consultation Sits On

Regardless of which platform a doctor uses, every online consultation in India operates under the Telemedicine Practice Guidelines issued by the Board of Governors in supersession of the Medical Council of India in March 2020, now overseen by the National Medical Commission. These guidelines remain the core framework as of 2026, with only interpretive guidance layered on top rather than a wholesale replacement, meaning any platform, however modern its interface, is subject to the same underlying rules that governed telemedicine consultations when the guidelines were first issued.

Only a Registered Medical Practitioner enrolled in the State Medical Register or Indian Medical Register can legally provide a telemedicine consultation, and this registration requirement travels with the doctor regardless of platform, meaning platform-side verification of a doctor’s credentials does not substitute for the doctor’s own responsibility to practise within the bounds of their registration and, where relevant, their specific scope of specialisation.

See also  National NCD Screening Mandates: What Primary Care in India Must Track

Prescribing Limits Apply Identically on Every Platform

The three-tier prescribing framework, List O for medicines safe to prescribe on a first consultation, List A for follow-up prescriptions, and List B for a more restricted set requiring stronger clinical justification, applies uniformly across every platform a doctor might use. Schedule X drugs and substances covered under the Narcotic Drugs and Psychotropic Substances Act cannot be prescribed via telemedicine on any platform, no matter how the platform’s own terms of service are worded.

Video consultation is treated as the gold standard for a genuine clinical assessment and is mandatory in certain situations, particularly first-time prescriptions for chronic conditions such as diabetes or hypertension, while audio and asynchronous store-and-forward consultations remain acceptable for follow-ups and lower-stakes queries. A doctor accepting consultations through a platform that defaults to text-only chat for first-time chronic disease management is taking on a compliance risk regardless of what the platform’s own policies claim to permit.

Verifying patient identity, ideally through a photo ID or ABHA ID, and obtaining and documenting explicit informed consent before beginning a consultation are requirements the doctor must personally satisfy, even when the platform provides identity-verification tooling as a convenience feature. Clinical records generated through platform consultations must be maintained for at least three years, and the doctor, not the platform, carries the professional and legal accountability if those records are later found incomplete or improperly retained.

Doctors are also liable for negligence through a telemedicine consultation exactly as they would be in a physical examination, meaning platform terms disclaiming the platform’s own liability for clinical outcomes do not reduce the doctor’s individual exposure, since disciplinary action under NMC regulations attaches to the treating doctor personally.

See also  Violence Against Doctors in India: Why a Central Law Still Doesn't Exist

Data Protection Adds a Newer Layer of Risk

The Digital Personal Data Protection Act brings meaningful financial penalty exposure for mishandling patient data, and casual use of unencrypted, non-clinical channels such as public messaging apps for consultation is now a genuine compliance risk rather than a grey area. Before joining any second-opinion or consultation platform, doctors should confirm the platform uses adequately secured, purpose-built medical consultation infrastructure rather than general-purpose consumer video or chat tools, and should check whether the platform integrates with ABDM and ABHA-linked record sharing, which is increasingly expected, particularly for platforms connected to government scheme empanelled hospitals.

Doctors should also review what data-sharing or data-monetisation rights the platform agreement grants itself over consultation records and patient information, since this is an area where platform terms can vary considerably, and a doctor signing a standard-form agreement without review may be granting broader data rights to the platform than they realise.

Conclusion

Joining a second-opinion or online consultation platform is a genuinely useful way to extend a specialist practice, but the regulatory responsibility for every consultation still sits with the individual doctor, not the platform. Reading the platform agreement with the Telemedicine Practice Guidelines and DPDP Act obligations in mind, rather than assuming platform compliance automatically covers the doctor, remains the safer approach before signing up.

Researched Resources

1. Telemedicine Guidelines and Regulations in India 2026

2. Telemedicine Regulations in India 2026: Updated Guidelines and Compliance Tips for Clinics

3. Regulations on Online Medical Consultation That Indian Doctors Need to Know

4. Online medical consultation in India

See also  Genetic Testing and Counselling in India: Inside the Regulatory Gap

Disclaimer: This article is for general informational and educational purposes and reflects India’s telemedicine regulatory framework as understood at the time of writing; platform-specific terms and NMC guidance continue to evolve. It is not legal advice, and doctors should review platform agreements with a qualified legal advisor before signing up.

Vivek Chaudhary is a Technical Content Developer specializing in healthcare, health technology, and digital healthcare business solutions. He creates research-driven, SEO-focused content for doctors, clinics, hospitals, healthcare professionals, and patients, covering topics such as healthcare technology, patient engagement, clinic management, digital communication, and online visibility.

Vivek Chaudhary

<strong>Vivek Chaudhary</strong> is a Technical Content Developer specializing in<strong> healthcare, health technology, and digital healthcare business solutions</strong>. He creates research-driven, SEO-focused content for doctors, clinics, hospitals, healthcare professionals, and patients, covering topics such as healthcare technology, patient engagement, clinic management, digital communication, and online visibility.

0 comments

Top